Biofrontera AG
XETRA:B8F

Watchlist Manager
Biofrontera AG Logo
Biofrontera AG
XETRA:B8F
Watchlist
Price: 4.8219 EUR 0.98% Market Closed
Market Cap: 23m EUR

Wall Street
Price Targets

B8F Price Targets Summary
Biofrontera AG

There are no price targets for B8F.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biofrontera AG Competitors:
Price Targets
ARGX
argenx SE
25% Upside
ATX
Amplia Therapeutics Ltd
168% Upside
IMDX
Insight Molecular Diagnostics Inc
8% Upside
87S
Roivant Sciences Ltd
5% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
13% Upside
NGNE
Neurogene Inc
243% Upside
CHRS
Coherus BioSciences Inc
261% Upside
300896
Imeik Technology Development Co Ltd
35% Upside

Revenue
Forecast

Revenue Estimate
Biofrontera AG

For the last 1 year the compound annual growth rate for Biofrontera AG's revenue is 25%. The projected CAGR for the next 2 years is 32%.

25%
Past Growth
32%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Biofrontera AG

Operating Income forecast
is not available for
Biofrontera AG

Net Income
Forecast

Net Income Estimate
Biofrontera AG

Net Income forecast
is not available for
Biofrontera AG
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is B8F's stock price target?
Not Available

B8F doesn't have any price targets made by Wall Street professionals.

What is Biofrontera AG's Revenue forecast?
Projected CAGR
32%

For the last 1 year the compound annual growth rate for Biofrontera AG's revenue is 25%. The projected CAGR for the next 2 years is 32%.

Back to Top